- Home
- KXIN vs ACXP Comparison
KXIN vs ACXP Comparison
Compare KXIN & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KXIN
- ACXP
- Stock Information
- Founded
- KXIN 2015
- ACXP 2017
- Country
- KXIN China
- ACXP United States
- Employees
- KXIN N/A
- ACXP N/A
- Industry
- KXIN Retail-Auto Dealers and Gas Stations
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- KXIN Consumer Discretionary
- ACXP Health Care
- Exchange
- KXIN Nasdaq
- ACXP Nasdaq
- Market Cap
- KXIN 9.4M
- ACXP 9.1M
- IPO Year
- KXIN N/A
- ACXP 2021
- Fundamental
- Price
- KXIN $0.65
- ACXP $4.45
- Analyst Decision
- KXIN
- ACXP Strong Buy
- Analyst Count
- KXIN 0
- ACXP 3
- Target Price
- KXIN N/A
- ACXP $143.67
- AVG Volume (30 Days)
- KXIN 210.5K
- ACXP 88.7K
- Earning Date
- KXIN 01-01-0001
- ACXP 08-12-2025
- Dividend Yield
- KXIN N/A
- ACXP N/A
- EPS Growth
- KXIN N/A
- ACXP N/A
- EPS
- KXIN N/A
- ACXP N/A
- Revenue
- KXIN N/A
- ACXP N/A
- Revenue This Year
- KXIN N/A
- ACXP N/A
- Revenue Next Year
- KXIN N/A
- ACXP N/A
- P/E Ratio
- KXIN N/A
- ACXP N/A
- Revenue Growth
- KXIN N/A
- ACXP N/A
- 52 Week Low
- KXIN $0.64
- ACXP $3.80
- 52 Week High
- KXIN $29.54
- ACXP $44.90
- Technical
- Relative Strength Index (RSI)
- KXIN 35.67
- ACXP 38.08
- Support Level
- KXIN $0.68
- ACXP $4.40
- Resistance Level
- KXIN $0.74
- ACXP $7.15
- Average True Range (ATR)
- KXIN 0.07
- ACXP 0.61
- MACD
- KXIN -0.01
- ACXP 0.15
- Stochastic Oscillator
- KXIN 2.90
- ACXP 30.15
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.